177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
Published Online: 2024-09-?
Journal: The Lancet•Publisher: Elsevier BV
Authors: Aude Fléchon•Begoña Mellado•Celine Wilke•Daniel Castellano•Euloge Kpamegan•Guilhem Roubaud•Hakim Mahammedi•Hana Študentová•James Nagarajah•Johann S de Bono•Josep M Piulats•Karim Fizazi•Katja Lehnhoff•Ken Herrmann•Kim N Chi•Michael Crosby•Michael J Morris•Neal D Shore•Oliver Sartor•Samson Ghebremariam•Teri N Kreisl•Xiao X Wei•Álvaro Montesa-Pino
